Primary Glaucoma Triple Procedure with or without Adjunctive Mitomycin

E-PTFE (Gore-Tex®) implant with or without low-dosage mitomycin-C as an adjuvant in penetrating glaucoma surgery: 2 year randomized clinical trial

“…On the other hand, reports indicating no statistically significant difference in the overall outcome of phacotrabeculectomy between control and MMC groups of non-selected patients with POAG, or no significant difference in the cumulative success probability of MMC-augmented trabeculectomy compared to trabeculectomy alone, are not infrequent (Shin et al 1996;Tsai et al 2003).…”

Perspectives in trabecular surgery

“…Failure was defined as the need for additional antiglaucomatous surgical or laser treatment (except for laser suture lysis), including bleb needling revision, or the need for more than one medication to reduce lOP to the target pressure as described by Shin et al 51 The target pressure was set before surgery and implemented in accordance with our clinical practice. In the majority of patients undergoing long-term therapy, we regarded the lOPs at which there was no progression of the glaucomatous optic nerve damage as acceptable target pressures.…”

A review of trabeculectomy in East Asian people—the influence of race

“…It was established early on in its history that trabeculectomy in black subjects failed earlier compared to white subjects, presumably due to a more vigorous fibrotic response in the subconjunctival space. [16][17][18][19][20][21][22] The reason black populations were studied in preference to the East Asian populations, for example, was probably because comparatively large communities of African-American blacks in the USA and Afro-Caribbean blacks in the UK provided a ready population to study in the countries where most of the academic literature was arising from.…”